Eurofins Scientific SE (the "Company") (EUFI.PA) (Paris:ERF) announces its intention to launch a new buy-back programme of its own shares (ISIN FR0014000MR3) for a maximum amount representing up to 4.

UL Solutions Inc. (NYSE:ULS) is one of the best IPO stocks to buy in 2026. On April 13, UL Solutions entered into a definitive agreement to acquire the Electrical & Electronics/E&E business of ...

Eurofins Scientific (EUFI.PA), a global leader in BioPharma Product Testing, announces the closing of its acquisition of Infinity Laboratories, Inc. ("Infinity"). Founded in 1991, Infinity operates ...

Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow ...

Eurofins is Testing for Life. The Eurofins Scientific SE network of independent companies believes that it is a global leader in food, environment, pharmaceutical and cosmetic product testing and in ...

In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins ...

Eurofins Scientific shares jumped after the Luxembourg laboratory testing group agreed to sell its electrical and electronics testing division, MET Labs, to Illinois-based UL Solutions. Shares in ...

Eurofins Lancaster Laboratories plans to break ground this spring on a $147 million expansion that will add biopharmaceutical testing labs and office space. Construction on the connected five- and six ...

Eurofins Scientific (ERFSF) has signed an agreement to sell its Electrical & Electronic Testing business, MET Labs, to UL Solutions Inc. for €575 million, on a cash and debt-free basis. MET Labs is ...

Thanks in part to an investment from Canada’s Strategic Innovation Fund (SIF), Eurofins CDMO is building a new biologics manufacturing facility at its site in Mississauga, Ontario, just outside of ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Shares in French diagnostic and testing group Eurofins tumbled as much as 23 per cent on Monday after hedge ...

Eurofins Lancaster Laboratories on Monday announced that it will add a new 300,000-square-foot biopharmaceutical testing facility and office to its Leola campus, costing about $147 million and adding ...